472 related articles for article (PubMed ID: 28912674)
1. A Mechanistic Understanding of Axon Degeneration in Chemotherapy-Induced Peripheral Neuropathy.
Fukuda Y; Li Y; Segal RA
Front Neurosci; 2017; 11():481. PubMed ID: 28912674
[TBL] [Abstract][Full Text] [Related]
2. A Comparative Review of Chemotherapy-Induced Peripheral Neuropathy in In Vivo and In Vitro Models.
Eldridge S; Guo L; Hamre J
Toxicol Pathol; 2020 Jan; 48(1):190-201. PubMed ID: 31331249
[TBL] [Abstract][Full Text] [Related]
3. Targeting Axon Integrity to Prevent Chemotherapy-Induced Peripheral Neuropathy.
Chine VB; Au NPB; Kumar G; Ma CHE
Mol Neurobiol; 2019 May; 56(5):3244-3259. PubMed ID: 30117103
[TBL] [Abstract][Full Text] [Related]
4. CD8+ T Cells and Endogenous IL-10 Are Required for Resolution of Chemotherapy-Induced Neuropathic Pain.
Krukowski K; Eijkelkamp N; Laumet G; Hack CE; Li Y; Dougherty PM; Heijnen CJ; Kavelaars A
J Neurosci; 2016 Oct; 36(43):11074-11083. PubMed ID: 27798187
[TBL] [Abstract][Full Text] [Related]
5. The Role of NMNAT2/SARM1 in Neuropathy Development.
Tarasiuk O; Molteni L; Malacrida A; Nicolini G
Biology (Basel); 2024 Jan; 13(1):. PubMed ID: 38275737
[TBL] [Abstract][Full Text] [Related]
6. Meclizine and Metabotropic Glutamate Receptor Agonists Attenuate Severe Pain and Ca
Shannonhouse J; Bernabucci M; Gomez R; Son H; Zhang Y; Ai CH; Ishida H; Kim YS
J Neurosci; 2022 Aug; 42(31):6020-6037. PubMed ID: 35772967
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy-induced neuropathy: A comprehensive survey.
Miltenburg NC; Boogerd W
Cancer Treat Rev; 2014 Aug; 40(7):872-82. PubMed ID: 24830939
[TBL] [Abstract][Full Text] [Related]
8. Paclitaxel Reduces Axonal Bclw to Initiate IP
Pease-Raissi SE; Pazyra-Murphy MF; Li Y; Wachter F; Fukuda Y; Fenstermacher SJ; Barclay LA; Bird GH; Walensky LD; Segal RA
Neuron; 2017 Oct; 96(2):373-386.e6. PubMed ID: 29024661
[TBL] [Abstract][Full Text] [Related]
9. Axonal degeneration in chemotherapy-induced peripheral neurotoxicity: clinical and experimental evidence.
Park SB; Cetinkaya-Fisgin A; Argyriou AA; Höke A; Cavaletti G; Alberti P
J Neurol Neurosurg Psychiatry; 2023 Nov; 94(11):962-972. PubMed ID: 37015772
[TBL] [Abstract][Full Text] [Related]
10. Considerations for a Reliable In Vitro Model of Chemotherapy-Induced Peripheral Neuropathy.
Eldridge S; Scuteri A; Jones EMC; Cavaletti G; Guo L; Glaze E
Toxics; 2021 Nov; 9(11):. PubMed ID: 34822690
[TBL] [Abstract][Full Text] [Related]
11. Prevention and Management of Chemotherapy-Induced Polyneuropathy.
Jordan B; Jahn F; Sauer S; Jordan K
Breast Care (Basel); 2019 Apr; 14(2):79-84. PubMed ID: 31798378
[TBL] [Abstract][Full Text] [Related]
12. Blood molecular biomarkers for chemotherapy-induced peripheral neuropathy: From preclinical models to clinical practice.
Meregalli C; Bonomo R; Cavaletti G; Carozzi VA
Neurosci Lett; 2021 Apr; 749():135739. PubMed ID: 33600907
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal Antibody Targeting the Matrix Metalloproteinase 9 Prevents and Reverses Paclitaxel-Induced Peripheral Neuropathy in Mice.
Tonello R; Lee SH; Berta T
J Pain; 2019 May; 20(5):515-527. PubMed ID: 30471427
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic benefits of maintaining mitochondrial integrity and calcium homeostasis by forced expression of Hsp27 in chemotherapy-induced peripheral neuropathy.
Chine VB; Au NPB; Ma CHE
Neurobiol Dis; 2019 Oct; 130():104492. PubMed ID: 31176721
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy-induced peripheral neuropathy.
Fehrenbacher JC
Prog Mol Biol Transl Sci; 2015; 131():471-508. PubMed ID: 25744683
[TBL] [Abstract][Full Text] [Related]
16. Neuropathic Pain and Nerve Growth Factor in Chemotherapy-Induced Peripheral Neuropathy: Prospective Clinical-Pathological Study.
Velasco R; Navarro X; Gil-Gil M; Herrando-Grabulosa M; Calls A; Bruna J
J Pain Symptom Manage; 2017 Dec; 54(6):815-825. PubMed ID: 28797868
[TBL] [Abstract][Full Text] [Related]
17. Toxic neuropathies: Chemotherapy Induced Peripheral Neurotoxicity.
Alberti P; Cavaletti G; Cornblath DR
Curr Opin Neurol; 2019 Oct; 32(5):676-683. PubMed ID: 31306214
[TBL] [Abstract][Full Text] [Related]
18. Beyond symptomatic relief for chemotherapy-induced peripheral neuropathy: Targeting the source.
Ma J; Kavelaars A; Dougherty PM; Heijnen CJ
Cancer; 2018 Jun; 124(11):2289-2298. PubMed ID: 29461625
[TBL] [Abstract][Full Text] [Related]
19. Prevention and Treatment for Chemotherapy-Induced Peripheral Neuropathy: Therapies Based on CIPN Mechanisms.
Hu LY; Mi WL; Wu GC; Wang YQ; Mao-Ying QL
Curr Neuropharmacol; 2019; 17(2):184-196. PubMed ID: 28925884
[TBL] [Abstract][Full Text] [Related]
20. Pathobiology of cancer chemotherapy-induced peripheral neuropathy (CIPN).
Han Y; Smith MT
Front Pharmacol; 2013 Dec; 4():156. PubMed ID: 24385965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
